title: Natalizumab-associated cerebellar PML: a case report on how to slow down IRIS.
authors: Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany, florian.lauda@uni-ulm.de.
authors: F
authors: F
authors: Lauda
authors: T
authors: T
authors: Fangerau
authors: K
authors: K
authors: Javaheripour-Otto
authors: E
authors: E
authors: Pinkhardt
authors: J
authors: J
authors: Kassubek
authors: H
authors: H
authors: Tumani
mesh_terms: D000328:Adult; D002526:Cerebellar Diseases / Q000139:chemically induced*; D005260:Female; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000188:drug therapy / Q000209:etiology*; D007136:Immunoglobulins / Q000008:administration & dosage; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D007136:Immunoglobulins; D007155:Immunologic Factors; D000069442:Natalizumab